Twist Bioscience: The DNA Factory Approaching an Operational Turning Point

Twist Bioscience has revolutionized DNA manufacturing by printing genetic building blocks on proprietary silicon chips instead of traditional test tubes on a large scale. With its two strong revenue pillars, DNA synthesis and next-generation sequencing (NGS), the company benefits from high-margin sales to the pharmaceutical, research, and diagnostics sectors. After years of dynamic revenue growth and massive efficiency improvements, Twist is on the verge of reaching operational break-even in the coming years. Synthetic biology is considered...